AG Scientific
 |
||
AG Scientific está especializada en metabolitos secundarios derivados de la fermentación. La mayoría de sus productos son antibióticos para la selección de genes, pero el catálogo también incluye reactivos antimicrobianos, antifúngicos, anticancerígenos, antivirales, antiparasitarios e inmunosupresores.
Antibióticos:
AG Scientific, Inc. ha desarrollado una serie de agentes antibióticos de cribado, como Blasticidin S, G-418, Puromycin, Gentamycin, Kanamycin, Ampicillin, Streptomycin, Carbenicillin.
Más recientemente, AG Scientific se ha asociado con clientes farmacéuticos que utilizan la tecnología CRISPR.
Anticancerígenos:
El catálogo incluye metabolitos secundarios en el campo del cáncer como rapamicina, FK-506, ciclosporina A.
Página web: www.agscientific.com
| ||
SARS-CoV-2 - Deferoxamine - Therapeutic Candidates
Deferoxamine (or Desferal) is a linear bacterial siderophore and chelating agent for trivalent cations. Deferoxamine is capable of binding free iron from plasma or cells to form the ferrioxamine complex. Due to its properties, deferoxamine is used as a first-line treatment for iron overload. Desferal is prescribed for various pathologies such as primary hemochromatosis, secondary hemosiderosis, acute martial intoxication, aluminum poisoning.
Deferoxamine has been included in some clinical studies to develop a treatment for COVID-19 caused by the SARS-CoV-2 coronavirus. Indeed, studies have shown that the replication of some RNA viruses, such as HIV-1 or cytomegalovirus, can be influenced by iron. Deferoxamine was able to inhibit viral replication in cells in vitro. For this reason, deferoxamine is being tested as part of the development of a treatment for COVID-19.
Resultados de su búsqueda : 0 Producto encontrado
Refine su búsqueda :
RUOCE / IVD
Referencia
Descripción
Cond.
Precio Sin IVA
‹
›